"Ginkgo biloba" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The only specie of the genus Ginkgo, family Ginkgoacea. It is the source of extracts of medicinal interest, especially Egb 761. Ginkgo may refer to the genus or species.
| Descriptor ID |
D020441
|
| MeSH Number(s) |
B01.650.940.800.575.912.125
|
| Concept/Terms |
Ginkgo biloba- Ginkgo biloba
- Ginkgo bilobas
- bilobas, Ginkgo
- Gingko
- Gingkos
- Gingko biloba
- Gingko bilobas
- bilobas, Gingko
- Ginkgo
- Ginkgos
- Ginko
- Ginkos
- Maidenhair Tree
- Maidenhair Trees
- Tree, Maidenhair
- Trees, Maidenhair
|
Below are MeSH descriptors whose meaning is more general than "Ginkgo biloba".
Below are MeSH descriptors whose meaning is more specific than "Ginkgo biloba".
This graph shows the total number of publications written about "Ginkgo biloba" by people in this website by year, and whether "Ginkgo biloba" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ginkgo biloba" by people in Profiles.
-
Ginkgo biloba for Tardive Dyskinesia and Plasma MnSOD Activity: Association with MnSOD Ala-9Val Variant: A Randomized, Double-blind Trial. Curr Neuropharmacol. 2024; 22(14):2443-2452.
-
Interventions for cognitive problems in adults with brain cancer: A narrative review. Eur J Cancer Care (Engl). 2019 May; 28(3):e13088.
-
Ginkgo biloba L. attenuates spontaneous recurrent seizures and associated neurological conditions in lithium-pilocarpine rat model of temporal lobe epilepsy through inhibition of mammalian target of rapamycin pathway hyperactivation. J Ethnopharmacol. 2017 May 23; 204:8-17.
-
Extract of Ginkgo biloba is equivalent to vitamin E in attenuating and preventing vacuous chewing movements in a rat model of tardive dyskinesia. Behav Pharmacol. 2013 Oct; 24(7):610-6.
-
Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba. Biol Psychiatry. 2012 Oct 15; 72(8):700-6.
-
Clonazepam quiets tinnitus: a randomised crossover study with Ginkgo biloba. J Neurol Neurosurg Psychiatry. 2012 Aug; 83(8):821-7.
-
Extract of Ginkgo biloba treatment for tardive dyskinesia in schizophrenia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2011 May; 72(5):615-21.
-
Ginkgo biloba extract kaempferol inhibits cell proliferation and induces apoptosis in pancreatic cancer cells. J Surg Res. 2008 Jul; 148(1):17-23.
-
Ginkgolide A attenuates homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg. 2006 Oct; 44(4):853-62.
-
The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial. Psychopharmacology (Berl). 2006 Sep; 188(1):12-7.